Bargossi AM, Grossi G, Fiorella PL, Gaddi A, Di Giulio R, Battino M.
Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction by HMG-CoA
reductase inhibitors. Mol Aspects Med. 1994;15(Suppl):S187-S193.
Chan A, Reichmann H, Kogel A, Beck A, Gold R. Metabolic changes in patients
with mitochondrial myopathies and effects of coenzyme Q10 therapy. J
Neurol. 1998;245:681-685.
Chopra RK, Goldman R, Sinatra ST, Bhagavan HN. Relative bioavailability of
coenzyme Q10 formulations in human subjects. Int J Vitam Nutr Res.
1998;68:109-113.
Danysz A, Oledzka K, Bukowska-Kiliszek M. Influence of coenzyme Q-10 on the
hypotensive effects of enalapril and nitrendipine in spontaneously hypertensive
rats. Pol J Pharmacol. 1994;46(5):457-461.
De Pinieux G, Chariot P, Ammi-Said M, et al. Lipid-lowering drugs and
mitochondrial function: effects of HMG-CoA reductase inhibitors on serum
ubiquinone and blood lactate/pyruvate levels.
Br J Clin Pharmacol. 1996;42(3):333-337.
Haas EM. Staying Healthy with Nutrition. Berkley, Calif: Celestial
Arts Publishing; 1992:65-79.
Iarussi D, Auricchio U, Agretto A, Murano A, Giuliano M, Casale F, et al.
Protective effect of coenzyme Q on anthracylines cardiotoxicity: Control study
in children with acute lymphoblastic leukemia and non-hodgkin lymphoma. Molec
Aspects Med. 1994;15(Suppl):S207-S212.
Jolliet P, Simon N, Barre J, et al. Plasma coenzyme Q10 concentrations in
breast cancer: prognosis and therapeutic consequences. Int J Clin Pharmacol
Therapeu. 1998;36:506-509.
Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10 (see
comments)]. Ugeskr Laeger. 1998;160(22):3225-3227.
Matthews RT, Yang L, Browne S, Baik M, Beal MF. Coenzyme Q10 administration
increases brain mitochondrial concentrations and exerts neuroprotective effects.
Proc Natl Acad Sci USA. July 21, 1998; 95:8892-8897.
Murray MT. Encyclopedia of Nutritional Supplements. Rocklin, Calif:
Prima Publishing; 1996:296-308.
Murray MT, Pizzorno JE. Encyclopedia of Natural Medicine. 2nd ed.
Rocklin, Calif: Prima Publishing; 1996.
Niibori K, Yokoyama H, Crestanello JA, Whitman GJ. Acute administration of
liposomal coenzyme Q10 increases myocardial tissue levels and improves tolerance
to ischemia reperfusion injury. J Surg Res. 1998;79:141-145.
Portakal O, Inal-Erden M. Effects of pentoxifylline and coenzyme Q10 in
hepatic ischemia/reperfusion injury. Clin Biochem. 1999;32:461-466.
Shils ME, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and
Disease. 9th ed. Baltimore, Md: Williams & Wilkins; 1999:90-92:
1377-1378.
Shinozawa S, Kawasaki H, Gomita Y. [Effect of biological membrane stabilizing
drugs (coenzyme Q10, dextran sulfate and reduced glutathione) on adriamycin
(doxorubicin)-induced toxicity and microsomal lipid peroxidation in mice].
Gan To Kagaku Ryoho. 1996;23(1):93-98.
Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble
coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients
with coronary artery disease. J Hum Hypertens. 1999;13(3):203-208.
Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind
placebo-controlled trial of coenzyme Q10 in patients with acute myocardial
infarction. Cardiovasc Drugs Ther. 1998;12:347-353.
Spigset O. Reduced effect of warfarin caused by ubidecarenone. The
Lancet. 1994;344:1372-1373.
Takahashi N, Iwasaka T, Sugiura T, et al. Effect of coenzyme Q10 on
hemodynamic response to ocular timolol. J Cardiovasc Pharmacol.
1989;14:462-468.
Werbach MR. Nutritional Influences on Illness. 2nd ed. Tarzana, Calif:
Third Line Press; 1993:66, 119, 122, 179, 421.
Zhou Q, Chan E. Accuracy of repeated blood sampling in rats: A new technique
applied in pharmacokinetic/pharmacodynamic studies of the interaction between
warfarin and Co-enzyme Q10.
J Pharmacol Toxicol Methods.
1998;40(4):191-199.